UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 75 filers reported holding UTAH MED PRODS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $495,876 | -6.9% | 5,766 | +0.9% | 0.00% | 0.0% |
| Q2 2023 | $532,452 | +6.8% | 5,713 | +8.6% | 0.00% | 0.0% |
| Q1 2023 | $498,680 | -10.4% | 5,262 | -5.0% | 0.00% | -33.3% |
| Q4 2022 | $556,635 | +17.9% | 5,537 | 0.0% | 0.00% | +50.0% |
| Q3 2022 | $472,000 | -0.8% | 5,537 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $476,000 | +43.8% | 5,537 | +50.1% | 0.00% | +100.0% |
| Q1 2022 | $331,000 | -10.3% | 3,688 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $369,000 | +7.9% | 3,688 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $342,000 | -2.8% | 3,688 | -10.9% | 0.00% | 0.0% |
| Q2 2021 | $352,000 | -1.7% | 4,138 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $358,000 | +44.4% | 4,138 | +40.4% | 0.00% | +100.0% |
| Q4 2020 | $248,000 | +5.5% | 2,947 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $235,000 | -0.4% | 2,947 | +10.6% | 0.00% | 0.0% |
| Q2 2020 | $236,000 | – | 2,665 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN DEMPSEY CAPITAL MANAGEMENT LLC | 165,563 | $9,464,000 | 2.95% |
| Bares Capital Management | 398,937 | $22,803,000 | 1.97% |
| Ativo Capital Management LLC | 7,072 | $404,000 | 0.18% |
| Penobscot Investment Management Company, Inc. | 7,400 | $423,000 | 0.15% |
| Wallace Capital Management Inc. | 10,001 | $572,000 | 0.13% |
| Ancora Advisors LLC | 11,389 | $651,000 | 0.10% |
| Hillsdale Investment Management Inc. | 4,400 | $252,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 36,300 | $2,075,000 | 0.06% |
| CRAWFORD INVESTMENT COUNSEL INC | 16,380 | $936,000 | 0.03% |
| Teton Advisors, Inc. | 5,174 | $296,000 | 0.02% |